Picture of Zoetis logo

ZTS Zoetis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Leerink starts coverage of animal health firms, sees vet clinic visits improving

** Brokerage Leerink Partners initiates coverage of three companies in the animal health
space, IDEXX  IDXX.O , Zoetis   ZTS.N , and Elanco  ELAN.N  
    ** Leerink says ELAN is set for a return to growth with the launches of newer drugs for
dogs, Zenrelia for itching and Credelio Quattro for parasitic infections, but the magnitude of
the growth remains a question 
    ** Brokerage is also cautious on the go-to-market investments for the drugs and said that
its survey showed a lukewarm interest in Zenrelia 
    ** IDXX, which offers diagnostics for animals, has been hurt by a slowdown in pet clinic
visits due to inflationary pressures alongside persistent staffing challenges at clinics
    ** "The slowdown in vet visits appears to be ameliorating per our survey, which gives us
more confidence in its growth prospects" — Leerink
    ** For ZTS, brokerage says it projects strong uptake of the company's newer osteoarthritis
pain products with continued strength in eczema and parasiticides
    

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com))

Recent news on Zoetis

See all news